Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Reyno

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Treatment Reviews|July 1, 1994
SuraminM A Eisenberger, L M Reyno
Patient Education and Counseling|October 8, 2003
Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancerE Irwin, A Arnold, T J Whelan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancerL M Reyno, M N Levine, P Skingley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 29, 1998
Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suraminR Sridhara, M A Eisenberger, V J Sinibaldi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Effects of storage on the binding of carboplatin to plasma proteinsK Erkmen, M J Egorin, L M Reyno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapyR Sridhara, M A Eisenberger, V J Sinibaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Development and validation of a pharmacokinetically based fixed dosing scheme for suraminL M Reyno, M J Egorin, M A Eisenberger, et al.
Cancer Research|October 15, 1994
Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor modelM J Chang, W D Yu, L M Reyno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancerL M Reyno, M J Egorin, R M Canetta, et al.
Seminars in Oncology|October 1, 1994
Modeling toxicity and response in carboplatin-based combination chemotherapyM J Egorin, L M Reyno, R M Canetta, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Treatment Reviews|July 1, 1994
SuraminM A Eisenberger, L M Reyno
Patient Education and Counseling|October 8, 2003
Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancerE Irwin, A Arnold, T J Whelan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancerL M Reyno, M N Levine, P Skingley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 29, 1998
Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suraminR Sridhara, M A Eisenberger, V J Sinibaldi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Effects of storage on the binding of carboplatin to plasma proteinsK Erkmen, M J Egorin, L M Reyno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapyR Sridhara, M A Eisenberger, V J Sinibaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Development and validation of a pharmacokinetically based fixed dosing scheme for suraminL M Reyno, M J Egorin, M A Eisenberger, et al.
Cancer Research|October 15, 1994
Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor modelM J Chang, W D Yu, L M Reyno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancerL M Reyno, M J Egorin, R M Canetta, et al.
Seminars in Oncology|October 1, 1994
Modeling toxicity and response in carboplatin-based combination chemotherapyM J Egorin, L M Reyno, R M Canetta, et al.
Pageof 2